Skip to main content
Get in Touch
9 + 2 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Speak to Our Experts
4 + 12 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.

Pharmaceutical Microbiology Testing

Aurigene Pharmaceutical Services pharmaceutical microbiology testing department has a BSL-2 compliant lab and a dedicated in-vivo facility for bacterial and fungal infection murine disease models. The team has vast experience in anti-infective drug discovery projects and ran several collaboration projects with innovator pharma companies to discover anti-bacterial and anti-fungal agents. Established in-vitro time-kill kinetics bioequivalence assays for generic products for regulatory submission.

 

Why Aurigene Pharmaceutical Services for Pharmaceutical Microbiology Testing?

Submissions to the US FDA and DCGI

Highly Qualified & Experienced Scientists

Audited by the US FDA with Zero 483 in 2019

BSL-2 Compliant Microbiology Lab

 

In-vitro pharmaceutical microbiology testing services include:

 
  • Pharmacodynamic studies: Drug-organism interaction
  • MIC and MBC: Susceptibility indicators; major parameters used to quantify the activity of an antibacterial agent against the target pathogen
  • Time kill kinetics: Information on the time course and rate of antimicrobial activity
  • PAE and PA-SME: Information on persistent effects of antibacterial agents
  • Resistance development and mutation frequency: Information on the rate of resistance
  • Others: Antimicrobial combination/effect of serum proteins on MIC/ biofilm studies
 

Our dedicated Microbiology labs offer a wide range of infectious models that can be tailored as per customer requirements

 

In-vivo Pharmaceutical Microbiology Testing 

 
  • Systemic infection models: Acute lethal model to generate POC and determine ED50 - primary screening
  • Respiratory tract infection models: Test efficacy of NCEs in highly vascularized tissue like lungs
  • Thigh infection models: Test efficacy of NCEs in poorly vascularized tissues like thighs
  • Urinary tract infection models: Testability of NCEs to clear UTIs
  • Organ burden models: Testability of NCEs to clear the disseminated infection
 

Virtual Tour

Contact Us

Country
1 + 0 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
x

You are about to leave Aurigene Pharmaceutical Services and affiliates website. Aurigene Pharmaceutical Services assumes no responsibility for the information presented on the external website or any further links from such sites. These links are presented to you only as a convenience, and the inclusion of any link does not imply endorsement by Aurigene Pharmaceutical Services.

If you wish to continue to this external website, click Proceed.

ProceedBack